Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A vs medical therapy in urge urinary incontinence
IRCT20230508058117N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of botulinum toxin type A in urge incontinence (2 arms), sponsored by Tehran University of Medical Sciences. Started Nov 2023; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
urge incontinence
Beyond the preview
Go deeper on IRCT20230508058117N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230508058117N1.